Kinetics of Polymorphic Phase Transformations of o-Aminobenzoic Acid: Application of a Dispersive Kinetic Model Plus Molecular Dynamics Simulation of Prenucleation Aggregates.
Peter J Skrdla, Benjamin J Coscia, Andrea Browning, John Shelley, Shiva Sekharan, Jacob Gavartin
{"title":"Kinetics of Polymorphic Phase Transformations of <i>o</i>-Aminobenzoic Acid: Application of a Dispersive Kinetic Model Plus Molecular Dynamics Simulation of Prenucleation Aggregates.","authors":"Peter J Skrdla, Benjamin J Coscia, Andrea Browning, John Shelley, Shiva Sekharan, Jacob Gavartin","doi":"10.1021/acs.molpharmaceut.5c00426","DOIUrl":null,"url":null,"abstract":"<p><p>The specific rate at which one crystalline phase converts to another can vary as a function of time under isothermal conditions. This behavior gives rise to sigmoidal kinetic transients that are characteristic of nucleation and growth. Such curves are commonly fitted using the Johnson-Mehl-Avrami-Erofe'ev-Kolmogorov (JMAEK) equation. However, due to the ambiguity surrounding the time exponent in the JMAEK model, we present an alternative two-parameter dispersive kinetic model (DKM) and apply it to the study of solution-mediated polymorphic conversions of the prototypical molecule, <i>o</i>-aminobenzoic acid (<i>o</i>-ABA) [Jiang, S.; Jansens, P. J.; ter Horst, J. H. Control over polymorph formation of <i>o</i>-aminobenzoic acid. <i>Cryst. Growth Des.</i> <b>2010</b>, <i>10</i>, 2541-2547]. Using our DKM, we reconstructed a distribution of activation energies, <i>D</i>(<i>E</i>), from each experimental transient. Then, using <i>D</i>(<i>E</i>), a corresponding particle size distribution (PSD) of the critical nuclei formed during phase transformation is predicted. Lastly, molecular dynamics (MD) simulations are performed to study the prenucleation aggregation behavior of <i>o</i>-ABA in solution, under experimentally relevant conditions, to complement the kinetic modeling of the macroscopic phase conversion in the solid state. We observe that <i>o</i>-ABA molecules weakly associate with each other to form a variety of \"loose\" aggregates. These aggregates are mostly dimers and trimers exhibiting H-bonding and π-π interactions in various configurations that generally do not conform to any of the known crystal packing arrangements of the most common <i>o</i>-ABA polymorphs. Therefore, the observed molecular self-association is more consistent with a nonclassical nucleation pathway whereby monomer densification occurs ahead of cluster formation and, eventually, structural ordering. Our molecular-level simulations in solution complement the original study performed using experimental measurements on bulk crystals, with the DKM serving to bridge the scale gap between the two approaches by providing a window into the nanoscale species (nuclei), ultimately impacting the overall rate of conversion.</p>","PeriodicalId":52,"journal":{"name":"Molecular Pharmaceutics","volume":" ","pages":""},"PeriodicalIF":4.5000,"publicationDate":"2025-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Pharmaceutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1021/acs.molpharmaceut.5c00426","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
The specific rate at which one crystalline phase converts to another can vary as a function of time under isothermal conditions. This behavior gives rise to sigmoidal kinetic transients that are characteristic of nucleation and growth. Such curves are commonly fitted using the Johnson-Mehl-Avrami-Erofe'ev-Kolmogorov (JMAEK) equation. However, due to the ambiguity surrounding the time exponent in the JMAEK model, we present an alternative two-parameter dispersive kinetic model (DKM) and apply it to the study of solution-mediated polymorphic conversions of the prototypical molecule, o-aminobenzoic acid (o-ABA) [Jiang, S.; Jansens, P. J.; ter Horst, J. H. Control over polymorph formation of o-aminobenzoic acid. Cryst. Growth Des.2010, 10, 2541-2547]. Using our DKM, we reconstructed a distribution of activation energies, D(E), from each experimental transient. Then, using D(E), a corresponding particle size distribution (PSD) of the critical nuclei formed during phase transformation is predicted. Lastly, molecular dynamics (MD) simulations are performed to study the prenucleation aggregation behavior of o-ABA in solution, under experimentally relevant conditions, to complement the kinetic modeling of the macroscopic phase conversion in the solid state. We observe that o-ABA molecules weakly associate with each other to form a variety of "loose" aggregates. These aggregates are mostly dimers and trimers exhibiting H-bonding and π-π interactions in various configurations that generally do not conform to any of the known crystal packing arrangements of the most common o-ABA polymorphs. Therefore, the observed molecular self-association is more consistent with a nonclassical nucleation pathway whereby monomer densification occurs ahead of cluster formation and, eventually, structural ordering. Our molecular-level simulations in solution complement the original study performed using experimental measurements on bulk crystals, with the DKM serving to bridge the scale gap between the two approaches by providing a window into the nanoscale species (nuclei), ultimately impacting the overall rate of conversion.
期刊介绍:
Molecular Pharmaceutics publishes the results of original research that contributes significantly to the molecular mechanistic understanding of drug delivery and drug delivery systems. The journal encourages contributions describing research at the interface of drug discovery and drug development.
Scientific areas within the scope of the journal include physical and pharmaceutical chemistry, biochemistry and biophysics, molecular and cellular biology, and polymer and materials science as they relate to drug and drug delivery system efficacy. Mechanistic Drug Delivery and Drug Targeting research on modulating activity and efficacy of a drug or drug product is within the scope of Molecular Pharmaceutics. Theoretical and experimental peer-reviewed research articles, communications, reviews, and perspectives are welcomed.